We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.14%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.7B
AUM Growth
+$211M
Cap. Flow
-$755M
Cap. Flow %
-5.94%
Top 10 Hldgs %
33.79%
Holding
1,215
New
45
Increased
450
Reduced
295
Closed
31

Top Buys

Rank Stock Value
1
VICI icon
VICI Properties
VICI
+$108M
2
VER
VEREIT, Inc.
VER
+$105M
3
WELL icon
Welltower
WELL
+$102M
4
VTR icon
Ventas
VTR
+$88.9M
5
BXP icon
Boston Properties
BXP
+$86.8M

Top Sells

Rank Stock Value
1
EQR icon
Equity Residential
EQR
+$189M
2
GGP
GGP Inc.
GGP
+$166M
3
KRC icon
Kilroy Realty
KRC
+$93.2M
4
ESRT icon
Empire State Realty Trust
ESRT
+$92.1M
5
EPR icon
EPR Properties
EPR
+$59.2M

Sector Composition

Rank Sector Weight
1 Real Estate 73.5%
2 Industrials 3.95%
3 Technology 3.75%
4 Financials 2.75%
5 Consumer Discretionary 2.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTCT icon
1051
PTC Therapeutics
PTCT
$6.37B
$8K ﹤0.01%
229
– –
AIMT
1052
DELISTED
Aimmune Therapeutics
AIMT
$8K ﹤0.01%
281
– –
ZGNX
1053
DELISTED
Zogenix, Inc.
ZGNX
$8K ﹤0.01%
189
– –
LXRX icon
1054
Lexicon Pharmaceuticals
LXRX
$1.02B
$7K ﹤0.01%
583
– –
PCRX icon
1055
Pacira BioSciences
PCRX
$1.02B
$7K ﹤0.01%
224
– –
SGMO
1056
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$7K ﹤0.01%
467
– –
TBPH icon
1057
Theravance Biopharma
TBPH
$874M
$7K ﹤0.01%
299
– –
TXMD icon
1058
TherapeuticsMD
TXMD
$23.8M
$7K ﹤0.01%
24
– –
GTHX
1059
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$7K ﹤0.01%
157
– –
IMGN
1060
DELISTED
Immunogen Inc
IMGN
$7K ﹤0.01%
731
– –
ACOR
1061
DELISTED
Acorda Therapeutics
ACOR
$7K ﹤0.01%
2
– –
RDUS
1062
DELISTED
Radius Health, Inc.
RDUS
$7K ﹤0.01%
246
– –
LMNX
1063
DELISTED
Luminex Corp
LMNX
$7K ﹤0.01%
243
– –
ARWR icon
1064
Arrowhead Research
ARWR
$12.1B
$6K ﹤0.01%
477
– –
ESPR
1065
DELISTED
Esperion Therapeutics
ESPR
$6K ﹤0.01%
145
– –
LKFT
1066
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$6K ﹤0.01%
60
– –
NTLA icon
1067
Intellia Therapeutics
NTLA
$1.5B
$6K ﹤0.01%
234
– –
QURE icon
1068
uniQure
QURE
$2.68B
$6K ﹤0.01%
170
– –
TVTX icon
1069
Travere Therapeutics
TVTX
$5.33B
$6K ﹤0.01%
217
– –
RVNC
1070
DELISTED
Revance Therapeutics, Inc.
RVNC
$6K ﹤0.01%
202
– –
EGRX
1071
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$6K ﹤0.01%
82
– –
ATNX
1072
DELISTED
Athenex, Inc. Common Stock
ATNX
$6K ﹤0.01%
16
– –
BOLD
1073
DELISTED
Audentes Therapeutics, Inc
BOLD
$6K ﹤0.01%
165
– –
ALDR
1074
DELISTED
Alder Biopharmaceuticals
ALDR
$6K ﹤0.01%
374
– –
AMRN
1075
Amarin Corp
AMRN
$284M
$5K ﹤0.01%
74
– –
41 42
43
44 45

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2018 Portfolio in Review

As of Q2 2018, Daiwa Securities Group held 1,215 positions worth $12.7B, up 1.7% from $12.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group withdrew a net $755M in Q2 2018, closing 31 positions and reducing 295 holdings. Its most notable exit was Blue Buffalo Pet Products, Inc, an estimated $5.82M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, up from 73% a quarter earlier, followed by Industrials and Technology.

Against the trend, Daiwa Securities Group opened a new position in VICI Properties worth $115M.

  • Daiwa Securities Group's largest Q2 2018 buy was VICI Properties: 5,575,176 shares worth $115M.
  • Daiwa Securities Group added most to VEREIT, Inc. in Q2 2018, an estimated $105M increase.
  • Daiwa Securities Group's biggest Q2 2018 reduction was Equity Residential, cutting an estimated $189M.
  • Daiwa Securities Group fully exited Blue Buffalo Pet Products, Inc in Q2 2018, selling an estimated $5.82M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $12.7B portfolio in Q2 2018.
  • Daiwa Securities Group opened 45 new positions and closed 31 in Q2 2018.
  • Daiwa Securities Group's portfolio value rose 1.7% quarter-over-quarter to $12.7B.

Based on Daiwa Securities Group's 13F filing for Q2 2018, filed 30 Jul 2018.